Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells
- 11 August 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 57 (12) , 1233-1240
- https://doi.org/10.1016/0024-3205(95)02069-u
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Proliferative responses of epithelial cells to 8‐bromo‐cyclic AMP and to a phorbol ester change during breast PathogenesisJournal of Cellular Physiology, 1994
- Prostaglandin E2 receptor heterogeneity and dysfunction in mammary tumor cellsJournal of Cellular Physiology, 1989
- Prostaglandin E2 and F2α inhibit growth of human gastric carcinoma cell line KATO III with simultaneous stimulation of cyclic AMP productionLife Sciences, 1989
- Application of bromodeoxyuridine incorporation measurements to the determination of cell distribution within the S phase of the cell cycleCytometry, 1988
- Nonsteroidal anti-inflammatory drugs stimulate 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytesJournal of Allergy and Clinical Immunology, 1984
- Effects of indomethacin on the growth of cultured mammary tumorsInternational Journal of Cancer, 1984
- Prostaglandins and cancer: A review of tumor initiation through tumor metastasisProstaglandins, 1981
- In vitro systems for evaluation of combination chemotherapyPharmacology & Therapeutics, 1980
- Initial Screening for Carcinogenicity of Commonly Used Drugs23JNCI Journal of the National Cancer Institute, 1980
- Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibitionProstaglandins, 1980